Premium
High control rates of proton‐ and carbon‐ion–beam treatment with intensity‐modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center
Author(s) -
Mattke Matthias,
Vogt Kira,
Bougatf Nina,
Welzel Thomas,
OelmannAvendano Jan,
Hauswald Henrik,
Jensen Alexandra,
Ellerbrock Malte,
Jäkel Oliver,
Haberer Thomas,
Herfarth Klaus,
Debus Jürgen,
Uhl Matthias
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31298
Subject(s) - nuclear medicine , medicine , proton therapy , chondrosarcoma , proton , carbon ion radiotherapy , irradiation , ion , radiation therapy , relative biological effectiveness , particle therapy , radiation treatment planning , radiology , chemistry , physics , nuclear physics , organic chemistry
BACKGROUND The current study compares the results of irradiation with protons and irradiation with carbon ions via a raster scan technique in patients with G1 and G2 skull base chondrosarcomas. METHODS Between 2009 and 2014, a total of 101 patients (40 men and 61 women) with a median age of 44 years (range, 19‐77 years) were irradiated with carbon ions (79 patients) or protons (22 patients) via a raster scan technique at the Heidelberg Ion Beam Therapy Center. The median total dose was 60 Gy (relative biological effectiveness [RBE]) at 3 Gy per fraction for carbon ions and 70 Gy (RBE) at 2 Gy per fraction for protons. The median boost planning target volume was 38 cm 3 (range, 8‐133 cm 3 ). Overall survival (OS) and local control (LC) were evaluated with the Kaplan‐Meier method. RESULTS The median follow‐up period was 40 months (range, 0.8‐78.1 months). At the start of the irradiation, all patients had residual macroscopic tumors. Five patients (5%) developed a local recurrence during the follow‐up. The 1‐, 2‐, and 4‐year LC rates were 100%, 100%, and 100%, respectively, for protons and 98.6%, 97.2%, and 90.5%, respectively, for carbon ions. The OS rates during the same periods of time were 100%, 100%, and 100%, respectively, for protons and 100%, 98.5%, and 92.9%, respectively, for carbon ions. An age ≤ 44 years was associated with a trend for a better outcome. No toxicity worse than Common Toxicity Criteria grade 3 was observed after treatment. CONCLUSIONS No significant difference between carbon ions and protons in the therapy of skull base chondrosarcoma could be detected in these initial retrospective results. Cancer 2018;124:2036‐44 . © 2018 American Cancer Society .